LISA O'NEIL: Open Payments
NPI 1215554324 · BISMARCK, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$230 in 11 payments from 6 companies in 2025. Trend: 2023 $177 · 2024 $194 · 2025 $230
Food & beverage: $230
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $70 |
| PFIZER INC. | 3 | $59 |
| Novo Nordisk Inc | 2 | $38 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $25 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $23 |
| Gilead Sciences, Inc. | 1 | $15 |
Products named: ELIQUIS, DALVANCE, UBRELVY, XIFAXAN, JOURNAVX, TEFLARO, Ozempic, Veklury.
Industry payments across ND — which companies pay providers there.
